TapewireFind a company

person · Reporting owner

Siurek Ryan H

Disclosed activity across 3 companies

Tapewire entity
20396
SEC CIK
0001476512

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
BIODESIX INCBDSX · Entity 6053Chief Accounting OfficerMay 08, 2023May 11, 2023
EverCommerce Inc.EVCM · Entity 4719Chief Financial OfficerSeptember 05, 2026September 08, 2026
VAIL RESORTS INCMTN · Entity 3943SVP, Controller & CAOSeptember 28, 2020September 30, 2020

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

BIODESIX INC

Report date May 08, 2023 · Filed May 11, 2023

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect42,288 Reported balance After 2023-05-08 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2023-05-08 · Exercise / conversion · Acquired 5,484 · Balance 42,288

F1: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock.

F2: Includes 9,643 shares purchased under the Issuer's Employee Stock Purchase Plan on February 28, 2023.

Common StockSEC Table I · non-derivativeDirect40,832 Reported balance After 2023-05-09 transaction · row 2 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 2 · 2023-05-09 · Sale · Disposed 1,456 · Balance 40,832

F3: These shares of the Issuer's common stock were sold automatically to cover taxes upon the vesting of RSUs.

F4: The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.53 to $1.6039, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Common StockSEC Table I · non-derivativeDirect40,268 Reported balance After 2023-05-10 transaction · row 3 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 3 · 2023-05-10 · Sale · Disposed 564 · Balance 40,268

F3: These shares of the Issuer's common stock were sold automatically to cover taxes upon the vesting of RSUs.

F5: The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.5332 to $1.615, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect21,193 Reported balance After 2023-05-08 transaction · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · 2023-05-08 · Exercise / conversion · Disposed 1,927 · Balance 21,193

F1: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock.

F6: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.

Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect3,557 Reported balance After 2023-05-08 transaction · row 5 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 5 · 2023-05-08 · Exercise / conversion · Disposed 3,557 · Balance 3,557

F1: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock.

F7: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.

Filing footnotes · ownership attribution and instrument terms

F1: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock.

F2: Includes 9,643 shares purchased under the Issuer's Employee Stock Purchase Plan on February 28, 2023.

F3: These shares of the Issuer's common stock were sold automatically to cover taxes upon the vesting of RSUs.

F4: The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.53 to $1.6039, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5: The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.5332 to $1.615, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.

F7: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.

EverCommerce Inc.

Report date September 05, 2026 · Filed September 08, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect336,713 Ending reported balance After 2026-09-05 transaction · row 2
2 source rows · reconciled sequence

Row 1 · 2026-09-05 · Tax withholding · Disposed 2,606 · Balance 339,513

F1: Represents the number of shares of common stock withheld by the Issuer to cover the reporting person's tax withholding obligation upon the vesting of Restricted Stock Units granted on March 5, 2025.

Row 2 · 2026-09-05 · Tax withholding · Disposed 2,800 · Balance 336,713

F2: Represents the number of shares of common stock withheld by the Issuer to cover the reporting person's tax withholding obligation upon the vesting of Restricted Stock Units granted on March 5, 2026.

Filing footnotes · ownership attribution and instrument terms

F1: Represents the number of shares of common stock withheld by the Issuer to cover the reporting person's tax withholding obligation upon the vesting of Restricted Stock Units granted on March 5, 2025.

F2: Represents the number of shares of common stock withheld by the Issuer to cover the reporting person's tax withholding obligation upon the vesting of Restricted Stock Units granted on March 5, 2026.

VAIL RESORTS INC

Report date September 28, 2020 · Filed September 30, 2020

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect609 Ending reported balance After 2020-09-28 transaction · row 5
5 source rows · reconciled sequence

Row 1 · 2020-09-28 · Exercise / conversion · Acquired 836 · Balance 1,445

Row 2 · 2020-09-28 · Tax withholding · Disposed 579 · Balance 866

F1: Shares of common stock were withheld from the issuance of common stock to the Reporting Person upon exercise in order to satisfy the Reporting Person's obligations for payment of the exercise price and withholding and other taxes due in connection therewith.

Row 3 · 2020-09-28 · Exercise / conversion · Acquired 2,133 · Balance 2,999

Row 4 · 2020-09-28 · Tax withholding · Disposed 1,681 · Balance 1,318

F1: Shares of common stock were withheld from the issuance of common stock to the Reporting Person upon exercise in order to satisfy the Reporting Person's obligations for payment of the exercise price and withholding and other taxes due in connection therewith.

Row 5 · 2020-09-28 · Sale · Disposed 709 · Balance 609

Share Appreciation RightSEC Table II · derivative / convertible security · Conversion / exercise price $129.64 · Expires 2026-05-01Direct0 Reported balance After 2020-09-28 transaction · row 6 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 6 · 2020-09-28 · Exercise / conversion · Disposed 836 · Balance 0

F2: On May 1, 2016, Reporting Person was granted 1,255 Share Appreciation Rights, which vested in three equal annual installments beginning on May 1, 2017.

Share Appreciation RightSEC Table II · derivative / convertible security · Conversion / exercise price $160.56 · Expires 2026-09-23Direct0 Reported balance After 2020-09-28 transaction · row 7 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 7 · 2020-09-28 · Exercise / conversion · Disposed 2,133 · Balance 0

F3: On September 23, 2016, Reporting Person was granted 3,200 Share Appreciation Rights, which vested in three equal annual installments beginning on September 23, 2017.

Filing footnotes · ownership attribution and instrument terms

F1: Shares of common stock were withheld from the issuance of common stock to the Reporting Person upon exercise in order to satisfy the Reporting Person's obligations for payment of the exercise price and withholding and other taxes due in connection therewith.

F2: On May 1, 2016, Reporting Person was granted 1,255 Share Appreciation Rights, which vested in three equal annual installments beginning on May 1, 2017.

F3: On September 23, 2016, Reporting Person was granted 3,200 Share Appreciation Rights, which vested in three equal annual installments beginning on September 23, 2017.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
March 01, 2023 Filed Mar 3, 2023 21:16 UTC BIODESIX INC BDSX · Entity 6053 GrantStock Options (Right to buy) · Derivative 114,204 $0.00 Strike: $2.00 $0.00
Disclosure

SEC source: 0001140361-23-010028 · form4.xml · derivative · entry 1

Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 114,204

Underlying: Common Stock · 114,204 shares

Expires 2033-02-28

F1 · derivative.exercise_date: This option vested in full on March 1, 2023. Under the Issuer's 2022 Bonus-to-Options Program, the Reporting Person elected to receive a portion of the annual cash bonus earned during 2022 in the form of a fully-vested option.

Read SEC document
February 09, 2023 Filed Feb 10, 2023 23:40 UTC BIODESIX INC BDSX · Entity 6053 SaleCommon Stock 2,016 $1.80 $3,626.99
Disclosure

SEC source: 0001140361-23-006075 · form4.xml · nonDerivative · entry 2

Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,161

F2 · kind: These shares of Issuer's common stock were sold automatically to cover taxes upon the vesting of RSUs.

F3 · price: The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.71 to $1.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 08, 2023 Filed Feb 10, 2023 23:40 UTC BIODESIX INC BDSX · Entity 6053 Exercise / conversionRestricted Stock Units · Derivative 3,556 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-006075 · form4.xml · derivative · entry 5

Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,114

Underlying: Common Stock · 3,556 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of Issuer's common stock.

F6 · derivative.exercise_date: These RSUs vest in a series of six successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.

F6 · derivative.expiration_date: These RSUs vest in a series of six successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.

Read SEC document
February 08, 2023 Filed Feb 10, 2023 23:40 UTC BIODESIX INC BDSX · Entity 6053 Exercise / conversionRestricted Stock Units · Derivative 1,927 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-006075 · form4.xml · derivative · entry 4

Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,120

Underlying: Common Stock · 1,927 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of Issuer's common stock.

F5 · derivative.exercise_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.

F5 · derivative.expiration_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.

Read SEC document
February 08, 2023 Filed Feb 10, 2023 23:40 UTC BIODESIX INC BDSX · Entity 6053 GrantRestricted Stock Units · Derivative 82,031 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-006075 · form4.xml · derivative · entry 3

Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,031

Underlying: Common Stock · 82,031 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of Issuer's common stock.

F4 · derivative.exercise_date: These RSUs vest in a series of four successive equal annual installments measured from February 8, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.

F4 · derivative.expiration_date: These RSUs vest in a series of four successive equal annual installments measured from February 8, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.

Read SEC document
February 08, 2023 Filed Feb 10, 2023 23:40 UTC BIODESIX INC BDSX · Entity 6053 Exercise / conversionCommon Stock 5,483 Not disclosed Not disclosed
Disclosure

SEC source: 0001140361-23-006075 · form4.xml · nonDerivative · entry 1

Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,177

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of Issuer's common stock.

Read SEC document
November 21, 2022 Filed Nov 21, 2022 23:03 UTC BIODESIX INC BDSX · Entity 6053 GrantCommon Stock 8,695 $1.15 $9,999.25
Disclosure

SEC source: 0001140361-22-042600 · form4.xml · nonDerivative · entry 1

Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,694

Read SEC document
November 10, 2022 Filed Nov 11, 2022 02:02 UTC BIODESIX INC BDSX · Entity 6053 SaleCommon Stock 762 $1.02 $775.34
Disclosure

SEC source: 0001140361-22-041077 · form4.xml · nonDerivative · entry 3

Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,999

F4 · kind: These Shares were sold automatically to cover taxes upon the vesting of RSUs.

F6 · price: The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.00 to $1.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
November 09, 2022 Filed Nov 11, 2022 02:02 UTC BIODESIX INC BDSX · Entity 6053 SaleCommon Stock 963 $1.04 $1,003.25
Disclosure

SEC source: 0001140361-22-041077 · form4.xml · nonDerivative · entry 2

Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,761

F4 · kind: These Shares were sold automatically to cover taxes upon the vesting of RSUs.

F5 · price: The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.00 to $1.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
November 08, 2022 Filed Nov 11, 2022 02:02 UTC BIODESIX INC BDSX · Entity 6053 Exercise / conversionRestricted Stock Units · Derivative 3,557 $0.00 $0.00
Disclosure

SEC source: 0001140361-22-041077 · form4.xml · derivative · entry 5

Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,670

Underlying: Common Stock · 3,557 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share").

F3 · derivative.exercise_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date.

F3 · derivative.expiration_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date.

Read SEC document
November 08, 2022 Filed Nov 11, 2022 02:02 UTC BIODESIX INC BDSX · Entity 6053 Exercise / conversionRestricted Stock Units · Derivative 1,925 $0.00 $0.00
Disclosure

SEC source: 0001140361-22-041077 · form4.xml · derivative · entry 4

Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,047

Underlying: Common Stock · 1,925 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share").

F2 · derivative.exercise_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date.

F2 · derivative.expiration_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date.

Read SEC document
November 08, 2022 Filed Nov 11, 2022 02:02 UTC BIODESIX INC BDSX · Entity 6053 Exercise / conversionCommon Stock 5,482 Not disclosed Not disclosed
Disclosure

SEC source: 0001140361-22-041077 · form4.xml · nonDerivative · entry 1

Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,724

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share").

Read SEC document
August 09, 2022 Filed Aug 10, 2022 22:54 UTC BIODESIX INC BDSX · Entity 6053 SaleCommon Stock 1,645 $2.53 $4,158.89
Disclosure

SEC source: 0001140361-22-029136 · form4.xml · nonDerivative · entry 2

Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,242

F4 · kind: These Shares were sold automatically to cover taxes upon the vesting of RSUs.

F5 · price: The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $2.38 to $2.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
August 08, 2022 Filed Aug 10, 2022 22:54 UTC BIODESIX INC BDSX · Entity 6053 Exercise / conversionRestricted Stock Units · Derivative 3,557 $0.00 $0.00
Disclosure

SEC source: 0001140361-22-029136 · form4.xml · derivative · entry 4

Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,227

Underlying: Common Stock · 3,557 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share").

F3 · derivative.exercise_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date.

F3 · derivative.expiration_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date.

Read SEC document
August 08, 2022 Filed Aug 10, 2022 22:54 UTC BIODESIX INC BDSX · Entity 6053 Exercise / conversionRestricted Stock Units · Derivative 1,927 $0.00 $0.00
Disclosure

SEC source: 0001140361-22-029136 · form4.xml · derivative · entry 3

Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,972

Underlying: Common Stock · 1,927 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share").

F2 · derivative.exercise_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date.

F2 · derivative.expiration_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date.

Read SEC document
August 08, 2022 Filed Aug 10, 2022 22:54 UTC BIODESIX INC BDSX · Entity 6053 Exercise / conversionCommon Stock 5,484 Not disclosed Not disclosed
Disclosure

SEC source: 0001140361-22-029136 · form4.xml · nonDerivative · entry 1

Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,887

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share").

Read SEC document
May 10, 2022 Filed May 12, 2022 01:42 UTC BIODESIX INC BDSX · Entity 6053 SaleCommon Stock 1,947 $1.83 $3,563.01
Disclosure

SEC source: 0001140361-22-018735 · form4.xml · nonDerivative · entry 2

Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,403

F4 · kind: These Shares were sold automatically to cover taxes upon the vesting of RSUs.

F5 · price: The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.73 to $1.945, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 09, 2022 Filed May 12, 2022 01:42 UTC BIODESIX INC BDSX · Entity 6053 Exercise / conversionRestricted Stock Units · Derivative 3,557 $0.00 $0.00
Disclosure

SEC source: 0001140361-22-018735 · form4.xml · derivative · entry 4

Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,784

Underlying: Common Stock · 3,557 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share").

F3 · derivative.exercise_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date.

F3 · derivative.expiration_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date.

Read SEC document
May 09, 2022 Filed May 12, 2022 01:42 UTC BIODESIX INC BDSX · Entity 6053 Exercise / conversionRestricted Stock Units · Derivative 1,927 $0.00 $0.00
Disclosure

SEC source: 0001140361-22-018735 · form4.xml · derivative · entry 3

Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,899

Underlying: Common Stock · 1,927 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share").

F2 · derivative.exercise_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date.

F2 · derivative.expiration_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date.

Read SEC document
May 09, 2022 Filed May 12, 2022 01:42 UTC BIODESIX INC BDSX · Entity 6053 Exercise / conversionCommon Stock 5,484 Not disclosed Not disclosed
Disclosure

SEC source: 0001140361-22-018735 · form4.xml · nonDerivative · entry 1

Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,350

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share").

F6 · balance_after: Includes 1,262 and 2,604 Shares acquired under the BDSX stock purchase plan on August 31, 2021 and February 28, 2022, respectively.

Read SEC document
March 10, 2022 Filed Mar 14, 2022 21:54 UTC BIODESIX INC BDSX · Entity 6053 GrantStock Options (Right to buy) · Derivative 30,887 $0.00 Strike: $2.29 $0.00
Disclosure

SEC source: 0001567619-22-006923 · doc1.xml · derivative · entry 1

Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,887

Underlying: Common Stock · 30,887 shares

Expires 2032-03-09

Read SEC document
February 08, 2022 Filed Feb 11, 2022 00:09 UTC BIODESIX INC BDSX · Entity 6053 GrantRestricted Stock Units · Derivative 21,341 $0.00 $0.00
Disclosure

SEC source: 0001140361-22-004590 · form4.xml · derivative · entry 2

Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,341

Underlying: Common Stock · 21,341 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

F3 · derivative.exercise_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date.

F3 · derivative.expiration_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date.

Read SEC document
February 08, 2022 Filed Feb 11, 2022 00:09 UTC BIODESIX INC BDSX · Entity 6053 GrantRestricted Stock Units · Derivative 30,826 $0.00 $0.00
Disclosure

SEC source: 0001140361-22-004590 · form4.xml · derivative · entry 1

Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,826

Underlying: Common Stock · 30,826 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

F2 · derivative.exercise_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date.

F2 · derivative.expiration_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date.

Read SEC document
January 07, 2021 Filed Jan 12, 2021 00:09 UTC BIODESIX INC BDSX · Entity 6053 GrantStock Options (Right to buy) · Derivative 45,000 $0.00 Strike: $19.16 $0.00
Disclosure

SEC source: 0000905148-21-000049 · form4.xml · derivative · entry 1

Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2031-01-06

F1 · date: This option vests 40% on December 31, 2022, and the remaining 60% in 36 successive, equal monthly installments measured from December 31, 2022.

F1 · kind: This option vests 40% on December 31, 2022, and the remaining 60% in 36 successive, equal monthly installments measured from December 31, 2022.

F1 · derivative.exercise_date: This option vests 40% on December 31, 2022, and the remaining 60% in 36 successive, equal monthly installments measured from December 31, 2022.

Read SEC document
September 28, 2020 Filed Sep 30, 2020 20:11 UTC VAIL RESORTS INC MTN · Entity 3943 Exercise / conversionShare Appreciation Right · Derivative 2,133 $0.00 Strike: $160.56 $0.00
Disclosure

SEC source: 0000812011-20-000094 · wf-form4_160149664839460.xml · derivative · entry 7

Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,133 shares

Expires 2026-09-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: On September 23, 2016, Reporting Person was granted 3,200 Share Appreciation Rights, which vested in three equal annual installments beginning on September 23, 2017.

Read SEC document
September 28, 2020 Filed Sep 30, 2020 20:11 UTC VAIL RESORTS INC MTN · Entity 3943 Exercise / conversionShare Appreciation Right · Derivative 836 $0.00 Strike: $129.64 $0.00
Disclosure

SEC source: 0000812011-20-000094 · wf-form4_160149664839460.xml · derivative · entry 6

Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 836 shares

Expires 2026-05-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: On May 1, 2016, Reporting Person was granted 1,255 Share Appreciation Rights, which vested in three equal annual installments beginning on May 1, 2017.

Read SEC document
September 28, 2020 Filed Sep 30, 2020 20:11 UTC VAIL RESORTS INC MTN · Entity 3943 SaleCommon Stock 709 $227.68 $161,425.12
Disclosure

SEC source: 0000812011-20-000094 · wf-form4_160149664839460.xml · nonDerivative · entry 5

Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 609

Read SEC document
September 28, 2020 Filed Sep 30, 2020 20:11 UTC VAIL RESORTS INC MTN · Entity 3943 Tax withholdingCommon Stock 1,681 $228.94 $384,848.14
Disclosure

SEC source: 0000812011-20-000094 · wf-form4_160149664839460.xml · nonDerivative · entry 4

Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,318

F1 · shares: Shares of common stock were withheld from the issuance of common stock to the Reporting Person upon exercise in order to satisfy the Reporting Person's obligations for payment of the exercise price and withholding and other taxes due in connection therewith.

Read SEC document
September 28, 2020 Filed Sep 30, 2020 20:11 UTC VAIL RESORTS INC MTN · Entity 3943 Exercise / conversionCommon Stock 2,133 $160.56 $342,474.48
Disclosure

SEC source: 0000812011-20-000094 · wf-form4_160149664839460.xml · nonDerivative · entry 3

Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,999

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 28, 2020 Filed Sep 30, 2020 20:11 UTC VAIL RESORTS INC MTN · Entity 3943 Tax withholdingCommon Stock 579 $228.94 $132,556.26
Disclosure

SEC source: 0000812011-20-000094 · wf-form4_160149664839460.xml · nonDerivative · entry 2

Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 866

F1 · shares: Shares of common stock were withheld from the issuance of common stock to the Reporting Person upon exercise in order to satisfy the Reporting Person's obligations for payment of the exercise price and withholding and other taxes due in connection therewith.

Read SEC document
September 28, 2020 Filed Sep 30, 2020 20:11 UTC VAIL RESORTS INC MTN · Entity 3943 Exercise / conversionCommon Stock 836 $129.64 $108,379.04
Disclosure

SEC source: 0000812011-20-000094 · wf-form4_160149664839460.xml · nonDerivative · entry 1

Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,445

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 27, 2020 Filed Sep 29, 2020 21:50 UTC VAIL RESORTS INC MTN · Entity 3943 Exercise / conversionRestricted Share Unit · Derivative 92 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000812011-20-000082 · wf-form4_160141622625007.xml · derivative · entry 9

Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 92 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: On September 27, 2017, Reporting Person was granted 275 RSUs, which vested in three equal annual installments beginning on September 27, 2018.

F6 · derivative.expiration_date: On September 27, 2017, Reporting Person was granted 275 RSUs, which vested in three equal annual installments beginning on September 27, 2018.

Read SEC document
September 27, 2020 Filed Sep 29, 2020 21:50 UTC VAIL RESORTS INC MTN · Entity 3943 Exercise / conversionRestricted Share Unit · Derivative 137 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000812011-20-000082 · wf-form4_160141622625007.xml · derivative · entry 8

Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 137

Underlying: Common Stock · 137 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: On September 27, 2018, Reporting Person was granted 412 RSUs, which vest in three equal annual installments beginning on September 27, 2019.

F5 · derivative.expiration_date: On September 27, 2018, Reporting Person was granted 412 RSUs, which vest in three equal annual installments beginning on September 27, 2019.

Read SEC document
September 27, 2020 Filed Sep 29, 2020 21:50 UTC VAIL RESORTS INC MTN · Entity 3943 Tax withholdingCommon Stock 40 $225.26 $9,010.40
Disclosure

SEC source: 0000812011-20-000082 · wf-form4_160141622625007.xml · nonDerivative · entry 6

Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 609

F3 · shares: 40 shares of common stock were withheld from the issuance of common stock to Reporting Person upon vesting of RSUs in order to satisfy the Reporting Person's obligations for payment of withholding and other taxes due in connection therewith.

Read SEC document
September 27, 2020 Filed Sep 29, 2020 21:50 UTC VAIL RESORTS INC MTN · Entity 3943 Exercise / conversionCommon Stock 137 $0.00 $0.00
Disclosure

SEC source: 0000812011-20-000082 · wf-form4_160141622625007.xml · nonDerivative · entry 5

Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 649

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 27, 2020 Filed Sep 29, 2020 21:50 UTC VAIL RESORTS INC MTN · Entity 3943 Tax withholdingCommon Stock 27 $225.26 $6,082.02
Disclosure

SEC source: 0000812011-20-000082 · wf-form4_160141622625007.xml · nonDerivative · entry 4

Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 512

F2 · shares: 27 shares of common stock were withheld from the issuance of common stock to Reporting Person upon vesting of RSUs in order to satisfy the Reporting Person's obligations for payment of withholding and other taxes due in connection therewith.

Read SEC document
September 27, 2020 Filed Sep 29, 2020 21:50 UTC VAIL RESORTS INC MTN · Entity 3943 Exercise / conversionCommon Stock 92 $0.00 $0.00
Disclosure

SEC source: 0000812011-20-000082 · wf-form4_160141622625007.xml · nonDerivative · entry 3

Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 539

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 25, 2020 Filed Sep 29, 2020 21:50 UTC VAIL RESORTS INC MTN · Entity 3943 Exercise / conversionRestricted Share Unit · Derivative 289 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000812011-20-000082 · wf-form4_160141622625007.xml · derivative · entry 7

Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 578

Underlying: Common Stock · 289 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: On September 25, 2019, Reporting Person was granted 867 RSUs, which vest in three equal annual installments beginning on September 25, 2020.

F4 · derivative.expiration_date: On September 25, 2019, Reporting Person was granted 867 RSUs, which vest in three equal annual installments beginning on September 25, 2020.

Read SEC document
September 25, 2020 Filed Sep 29, 2020 21:50 UTC VAIL RESORTS INC MTN · Entity 3943 Tax withholdingCommon Stock 84 $225.26 $18,921.84
Disclosure

SEC source: 0000812011-20-000082 · wf-form4_160141622625007.xml · nonDerivative · entry 2

Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 447

F1 · shares: 84 shares of common stock were withheld from the issuance of common stock to Reporting Person upon vesting of Restricted Stock Units (RSUs) in order to satisfy the Reporting Person's obligations for payment of withholding and other taxes due in connection therewith.

Read SEC document
September 25, 2020 Filed Sep 29, 2020 21:50 UTC VAIL RESORTS INC MTN · Entity 3943 Exercise / conversionCommon Stock 289 $0.00 $0.00
Disclosure

SEC source: 0000812011-20-000082 · wf-form4_160141622625007.xml · nonDerivative · entry 1

Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 531

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 30, 2019 Filed Oct 1, 2019 21:58 UTC VAIL RESORTS INC MTN · Entity 3943 SaleCommon Stock 100 $236.98 $23,698.00
Disclosure

SEC source: 0000812011-19-000120 · wf-form4_156996710335688.xml · nonDerivative · entry 7

Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 242

Read SEC document
September 30, 2019 Filed Oct 1, 2019 21:58 UTC VAIL RESORTS INC MTN · Entity 3943 SaleCommon Stock 700 $235.85 $165,095.00
Disclosure

SEC source: 0000812011-19-000120 · wf-form4_156996710335688.xml · nonDerivative · entry 6

Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 342

F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.55 to $236.52, inclusive. The Reporting Person undertakes to provide Vail Resorts, Inc., any security holder of Vail Resorts, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
September 30, 2019 Filed Oct 1, 2019 21:58 UTC VAIL RESORTS INC MTN · Entity 3943 SaleCommon Stock 98 $234.50 $22,981.00
Disclosure

SEC source: 0000812011-19-000120 · wf-form4_156996710335688.xml · nonDerivative · entry 5

Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,042

Read SEC document
September 27, 2019 Filed Oct 1, 2019 21:58 UTC VAIL RESORTS INC MTN · Entity 3943 Exercise / conversionRestricted Share Unit · Derivative 138 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000812011-19-000120 · wf-form4_156996710335688.xml · derivative · entry 9

Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 274

Underlying: Common Stock · 138 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: On September 27, 2018, Reporting Person was granted 412 RSUs, which vest in three equal annual installments beginning on September 27, 2019.

F3 · derivative.expiration_date: On September 27, 2018, Reporting Person was granted 412 RSUs, which vest in three equal annual installments beginning on September 27, 2019.

Read SEC document
September 27, 2019 Filed Oct 1, 2019 21:58 UTC VAIL RESORTS INC MTN · Entity 3943 Exercise / conversionRestricted Share Unit · Derivative 91 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000812011-19-000120 · wf-form4_156996710335688.xml · derivative · entry 8

Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92

Underlying: Common Stock · 91 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: On September 27, 2017, Reporting Person was granted 275 Restricted Share Units ("RSUs"), which vest in three equal annual installments beginning on September 27, 2018.

F1 · derivative.expiration_date: On September 27, 2017, Reporting Person was granted 275 Restricted Share Units ("RSUs"), which vest in three equal annual installments beginning on September 27, 2018.

Read SEC document
September 27, 2019 Filed Oct 1, 2019 21:58 UTC VAIL RESORTS INC MTN · Entity 3943 Tax withholdingCommon Stock 40 $236.98 $9,479.20
Disclosure

SEC source: 0000812011-19-000120 · wf-form4_156996710335688.xml · nonDerivative · entry 4

Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,140

F4 · shares: 40 shares of common stock were withheld from the issuance of common stock to Reporting Person upon vesting of RSUs in order to satisfy the Reporting Person's obligations for payment of withholding and other taxes due in connection therewith.

Read SEC document
September 27, 2019 Filed Oct 1, 2019 21:58 UTC VAIL RESORTS INC MTN · Entity 3943 Exercise / conversionCommon Stock 138 $0.00 $0.00
Disclosure

SEC source: 0000812011-19-000120 · wf-form4_156996710335688.xml · nonDerivative · entry 3

Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,180

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · shares: On September 27, 2018, Reporting Person was granted 412 RSUs, which vest in three equal annual installments beginning on September 27, 2019.

Read SEC document
September 27, 2019 Filed Oct 1, 2019 21:58 UTC VAIL RESORTS INC MTN · Entity 3943 Tax withholdingCommon Stock 27 $236.98 $6,398.46
Disclosure

SEC source: 0000812011-19-000120 · wf-form4_156996710335688.xml · nonDerivative · entry 2

Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,042

F2 · shares: 27 shares of common stock were withheld from the issuance of common stock to Reporting Person upon vesting of RSUs in order to satisfy the Reporting Person's obligations for payment of withholding and other taxes due in connection therewith.

Read SEC document
September 27, 2019 Filed Oct 1, 2019 21:58 UTC VAIL RESORTS INC MTN · Entity 3943 Exercise / conversionCommon Stock 91 $0.00 $0.00
Disclosure

SEC source: 0000812011-19-000120 · wf-form4_156996710335688.xml · nonDerivative · entry 1

Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,069

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On September 27, 2017, Reporting Person was granted 275 Restricted Share Units ("RSUs"), which vest in three equal annual installments beginning on September 27, 2018.

Read SEC document
September 25, 2019 Filed Sep 27, 2019 21:24 UTC VAIL RESORTS INC MTN · Entity 3943 GrantRestricted Share Unit · Derivative 867 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000812011-19-000104 · wf-form4_156961948034013.xml · derivative · entry 2

Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 867

Underlying: Common Stock · 867 shares

Expires not disclosed

F2 · derivative.exercise_date: On September 25, 2019, Reporting Person was granted 867 Restricted Share Units, which vest in three equal annual installments beginning on September 25, 2020.

F2 · derivative.expiration_date: On September 25, 2019, Reporting Person was granted 867 Restricted Share Units, which vest in three equal annual installments beginning on September 25, 2020.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.